University of Utah Looks to Commercialize Continuous Flow Microfluidic PCR Tech | GenomeWeb

With a freshly minted US patent in hand, the University of Utah Research Foundation has made available for licensing an ultra-fast PCR microchip technology that can perform real-time melt curve analysis in less time than existing commercial thermal cyclers.

The technology, which uses microfluidic channels to continuously flow a sample through different temperature zones, can theoretically complete 30 cycles of PCR in approximately six or seven minutes while measuring both bulk fluorescence and DNA melting after each cycle, according to its inventors.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.